Wheal Amanda J, Randall Michael D
Centre for Integrated Systems Biology & Medicine, School of Biomedical Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
Eur J Pharmacol. 2009 Jan 28;603(1-3):79-85. doi: 10.1016/j.ejphar.2008.11.061. Epub 2008 Dec 9.
The hypotensive actions of methanandamide are enhanced in anaesthetised spontaneously hypertensive rats (SHR), which may be due to increased sensory nerve activity. We have now investigated in vitro the role of sensory nerves and other vasorelaxant mechanisms of anandamide in this model of hypertension, and in rats made hypertensive by chronic inhibition of nitric oxide (NO) synthase. Male SHR and Sprague-Dawley rats (given approximately 10 mg/kg/day N(G) nitro-L-arginine methyl ester (L-NAME) to drink for 4 weeks) were used. Vasorelaxant responses to anandamide and capsaicin were determined in perfused mesenteric arterial beds and thoracic aortic rings. The contributions of sensory nerves, NO, prostanoids, cannabinoid receptors and the endothelium in these responses were investigated. In mesenteric arterial beds from SHR, anandamide was less potent as a vasorelaxant, but in aortae caused greater maximal relaxations compared to controls. The reduced potency in the mesenteric arterial bed was accompanied by impaired NO-dependent relaxation. Pre-treatment with capsaicin prevented the enhancement of vasorelaxation by anandamide in mesenteric arterial beds from rats with L-NAME-induced hypertension. The reduced potency of anandamide in mesenteric arterial beds from SHR was due to reduced NO-dependent vasorelaxation, and provides no evidence for increased sensory nerve activity. The enhanced responses in the SHR aortae were endothelium-dependent. However, in L-NAME-induced hypertension the enhanced vasorelaxation to anandamide in the mesenteric vasculature was due to increased sensory nerve-mediated activity. In conclusion, the alterations in responses to anandamide in hypertension are dependent on the vessels studied and the model of hypertension.
在麻醉的自发性高血压大鼠(SHR)中,甲胺大麻酰胺的降压作用增强,这可能是由于感觉神经活动增加所致。我们现在已经在体外研究了感觉神经在这种高血压模型以及慢性抑制一氧化氮(NO)合酶所致高血压大鼠中对anandamide的作用以及其他血管舒张机制。使用雄性SHR和Sprague-Dawley大鼠(给予约10mg/kg/天的N(G)硝基-L-精氨酸甲酯(L-NAME)饮用4周)。在灌注的肠系膜动脉床和胸主动脉环中测定对anandamide和辣椒素的血管舒张反应。研究了感觉神经、NO、前列腺素、大麻素受体和内皮在这些反应中的作用。在SHR的肠系膜动脉床中,anandamide作为血管舒张剂的效力较低,但与对照组相比,在主动脉中引起更大的最大舒张。肠系膜动脉床中效力的降低伴随着NO依赖性舒张的受损。用辣椒素预处理可防止L-NAME诱导的高血压大鼠肠系膜动脉床中anandamide增强血管舒张作用。SHR肠系膜动脉床中anandamide效力的降低是由于NO依赖性血管舒张作用降低,并且没有提供感觉神经活动增加的证据。SHR主动脉中增强的反应是内皮依赖性的。然而,在L-NAME诱导的高血压中,肠系膜血管对anandamide增强的血管舒张作用是由于感觉神经介导的活动增加。总之,高血压中对anandamide反应的改变取决于所研究的血管和高血压模型。